Systemic therapeutic options for severe atopic dermatitis

被引:30
作者
Bussmann, Caroline [1 ]
Bieber, Thomas [1 ]
Novak, Natalija [1 ]
机构
[1] Univ Bonn, Klin & Poliklin Dermatol & Allergol, D-53105 Bonn, Germany
来源
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2009年 / 7卷 / 03期
关键词
atopic dermatitis; systemic therapy; immunosuppressive drugs; antibiotics; immunotherapy; biologics; DOSE INTRAVENOUS IMMUNOGLOBULIN; ANTI-IGE THERAPY; DOUBLE-BLIND; IMMUNE GLOBULIN; NECK DERMATITIS; CYCLOSPORINE; ECZEMA; ADULT; METHOTREXATE; AZATHIOPRINE;
D O I
10.1111/j.1610-0387.2008.06834.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Systemic therapy of severe atopic dermatitis (AD) is difficult in some cases, because the use of immunosuppressive agents such as cyclosporine A, mofetil mycophenolate, tacrolimus, and azathioprine is limited by adverse reactions or contraindications. Recent reports suggest a helpful role for biologics, methotrexate, anti-IgE antibodies, and immunotherapy. We review the modes of action, as well as advantages and disadvantages of current and new systemic therapeutic options for severe AD.
引用
收藏
页码:205 / 219
页数:15
相关论文
共 71 条
[1]  
Abeck D, 1998, BRIT J DERMATOL, V139, P13
[2]   Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report [J].
Akdis, Cezmi A. ;
Akdis, Mubeccel ;
Bieber, Thomas ;
Bindslev-Jensen, Carsten ;
Boguniewicz, Mark ;
Eigenmann, Philippe ;
Hamid, Qutayba ;
Kapp, Alexander ;
Leung, Donald Y. M. ;
Lipozencic, Jasna K. ;
Luger, Thomas A. ;
Muraro, Antonella ;
Novak, Natalija ;
Platts-Mills, Thomas A. E. ;
Rosenwasser, Lanny ;
Scheynius, Annika ;
Simons, F. Estelle R. ;
Spergel, Jonathan ;
Turjanmaa, Kristiina ;
Wahn, Ulrich ;
Weidinger, Stefan ;
Werfel, Thomas ;
Zuberbier, Torsten .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (01) :152-169
[3]   KETOCONAZOLE IN ATOPIC-DERMATITIS - THERAPEUTIC RESPONSE IS CORRELATED WITH DECREASE IN SERUM IGE [J].
BACK, O ;
SCHEYNIUS, A ;
JOHANSSON, SGO .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1995, 287 (05) :448-451
[4]   Methotrexate in dermatology [J].
Bangert, Carolyn A. ;
Costner, Melissa I. .
DERMATOLOGIC THERAPY, 2007, 20 (04) :216-228
[5]   Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels [J].
Belloni, Benedetta ;
Ziai, Mahzad ;
Lim, Annick ;
Lemercier, Brigitte ;
Sbornik, Martin ;
Weidinger, Stephan ;
Andres, Christian ;
Schnopp, Christina ;
Ring, Johannes ;
Hein, Ruediger ;
Ollert, Markus ;
Mempel, Martin .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (05) :1223-1225
[6]   Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil [J].
Benez, A ;
Fierlbeck, G .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (03) :638-639
[7]   Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial [J].
Berth-Jones, J ;
Takwale, A ;
Tan, E ;
Barclay, G ;
Agarwal, S ;
Ahmed, I ;
Hotchkiss, K ;
Graham-Brown, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) :324-330
[8]   Cyclosporine in severe childhood atopic dermatitis: A multicenter study [J].
BerthJones, J ;
Finlay, AY ;
Zaki, I ;
Tan, B ;
Goodyear, H ;
LewisJones, S ;
Cork, MJ ;
Bleehen, SS ;
Salek, MS ;
Allen, BR ;
Friedmann, P ;
Harper, J ;
Camp, RDR ;
Smith, S ;
GrahamBrown, RAC .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 34 (06) :1016-1021
[9]   Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis [J].
BerthJones, J ;
GrahamBrown, BAC ;
Marks, B ;
Camp, RDR ;
English, JSC ;
Freeman, K ;
Holden, CA ;
Rogers, SCF ;
Oliwiecki, S ;
Friedmann, PS ;
LewisJones, MS ;
Archer, CB ;
Adriaans, B ;
Douglas, WS ;
Allen, BR .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) :76-81
[10]   Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis:: a possible new immune intervention [J].
Bottari, V ;
Frezzolini, A ;
Ruffelli, M ;
Puddu, P ;
Fontana, L ;
De Pità, O .
ALLERGY, 1999, 54 (05) :507-510